ß-catenin signaling is required for RAS-driven thyroid cancer through PI3K activation
Open Access
- 30 June 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (31) , 49435-49449
Abstract
ß-catenin signaling is required for RAS-driven thyroid cancer through PI3K activationKeywords
This publication has 68 references indexed in Scilit:
- β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient MelanomasCancer Cell, 2011
- Transcriptional Activation of ZEB1 by Slug Leads to Cooperative Regulation of the Epithelial–Mesenchymal Transition-Like Phenotype in MelanomaJournal of Investigative Dermatology, 2011
- Progression of BRAF-induced thyroid cancer is associated with epithelial–mesenchymal transition requiring concomitant MAP kinase and TGFβ signalingOncogene, 2011
- β-catenin tyrosine 654 phosphorylation increases Wnt signalling and intestinal tumorigenesisGut, 2011
- Phosphoinositide 3-Kinase Signaling Mediates β-Catenin Activation in Intestinal Epithelial Stem and Progenitor Cells in ColitisGastroenterology, 2010
- Genetic Alterations in the Phosphatidylinositol-3 Kinase/Akt Pathway in Thyroid CancerThyroid®, 2010
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signallingNature, 2009
- Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles forBRAF, PIK3CA, andAKT1Cancer Research, 2009
- Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional ActivityJournal of Biological Chemistry, 2007
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976